Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background/Aims: Long non-coding RNAs (lncRNAs) play important roles in diverse biological processes, such as cell growth, apoptosis and migration. Although downregulation of lncRNA maternally expressed gene 3 (MEG3) has been identified in several cancers, little is known about its role in prostate cancer progression. The aim of this study was to detect MEG3 expression in clinical prostate cancer tissues, investigate its biological functions in the development of prostate cancer and the underlying mechanism. Methods: MEG3 expression levels were detected by qRT-PCR in both tumor tissues and adjacent non-tumor tissues from 21 prostate cancer patients. The effects of MEG3 on PC3 and DU145 cells were assessed by MTT assay, colony formation assay, western blot and flow cytometry. Transfected PC3 cells were transplanted into nude mice, and the tumor growth curves were determined. Results: MEG3 decreased significantly in prostate cancer tissues relative to adjacent normal tissues. MEG3 inhibited intrinsic cell survival pathway in vitro and in vivo by reducing the protein expression of Bcl-2, enhancing Bax and activating caspase 3. We further demonstrated that MEG3 inhibited the expression of cell cycle regulatory protein Cyclin D1 and induced cell cycle arrest in G0/G1 phase. Conclusions: Our study presents an important role of MEG3 in the molecular etiology of prostate cancer and implicates the potential application of MEG3 in prostate cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
lincRNAs act in the circuitry controlling pluripotency and differentiation
Guttman, M., Donaghey, J., Carey, B. W., Garber, M., Grenier, J. K., Munson, G., Young, G., Lucas, A. B., Ach, R., Bruhn, L., et al. (2011) · Nature · doi:10.1038/nature10398 · Cited by 1,858
The hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis
Lakhani, S. A., Masud, A., Kuida, K., Porter, G. A., Booth, C. J., Mehal, W. Z., Inayat, I., & Flavell, R. A. (2006) · Science · doi:10.1126/science.1115035 · Cited by 1,178
Worldwide burden of cervical cancer in 2008
Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr015 · Cited by 1,130
Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Prensner, J. R., Iyer, M. K., Sahu, A., Asangani, I. A., Cao, Q., Patel, L., Vergara, I. A., Davicioni, E., Erho, N., Ghadessi, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2771 · Cited by 669
Activation of p53 by MEG3 Non-coding RNA
Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J., Weng, C., & Klibanski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702029200 · Cited by 653
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
Braconi, C., Kogure, T., Valeri, N., Huang, N., Nuovo, G., Costinean, S., Negrini, M., Miotto, E., Croce, C. M., & Patel, T. (2011) · Oncogene · doi:10.1038/onc.2011.193 · Cited by 642
Caspases in cell survival, proliferation and differentiation
Lamkanfi, M., Festjens, N., Declercq, W., Berghe, T. V., & Vandenabeele, P. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402047 · Cited by 561
Loblaw, D. A., Virgo, K. S., Nam, R., Somerfield, M. R., Ben-Josef, E., Mendelson, D. S., Middleton, R., Sharp, S. A., Smith, T. J., Talcott, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1949 · Cited by 555
Reed, J. C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401975 · Cited by 473
Lu, K.-H., Li, W., Liu, X.-H., Sun, M., Zhang, M.-L., Wu, W.-Q., Xie, W.-P., & Hou, Y.-Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-461 · Cited by 424
Overexpression of the long non‐coding RNA MEG3 impairs in vitro glioma cell proliferation
Wang, P., Ren, Z., & Sun, P. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24055 · Cited by 340
Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K. A., Zhou, Y., Cheunsuchon, P., Louis, D. N., & Klibanski, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3885 · Cited by 330
Ren, S., Liu, Y., Xu, W., Sun, Y., Lu, J., Wang, F., Wei, M., Shen, J., Hou, J., Gao, X., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.07.001 · Cited by 328
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J., Xu, M., Yan, J., et al. (2014) · The FEBS Journal · doi:10.1111/febs.12902 · Cited by 299
Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer
Ying, L., Huang, Y., Chen, H., Wang, Y., Xia, L., Chen, Y., Liu, Y., & Qiu, F. (2012) · Molecular BioSystems · doi:10.1039/c2mb25386k · Cited by 298
Sun, M., Xia, R., Jin, F., Xu, T., Liu, Z., De, W., & Liu, X. (2014) · Tumor Biology · doi:10.1007/s13277-013-1142-z · Cited by 296
Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1
Hanai, J.-I., Dhanabal, M., Karumanchi, S. A., Albanese, C., Waterman, M., Chan, B., Ramchandran, R., Pestell, R., & Sukhatme, V. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112274200 · Cited by 218
Cui, Z., Ren, S., Lu, J., Wang, F., Xu, W., Sun, Y., Wei, M., Chen, J., Gao, X., Xu, C., et al. (2013) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.11.030 · Cited by 187
Identification and function of long non-coding RNA
Ernst, C., & Morton, C. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00168 · Cited by 173
Still embedded together binding to membranes regulates Bcl-2 protein interactions
Leber, B., Lin, J., & Andrews, D. W. (2010) · Oncogene · doi:10.1038/onc.2010.283 · Cited by 167
Loss of Imprinting and Allelic Switching at the DLK1-MEG3 Locus in Human Hepatocellular Carcinoma
Anwar, S. L., Krech, T., Hasemeier, B., Schipper, E., Schweitzer, N., Vogel, A., Kreipe, H. H., & Lehmann, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049462 · Cited by 141
Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens
Westdorp, H., Sköld, A. E., Snijer, B. A., Franik, S., Mulder, S. F., Major, P. P., Foley, R., Gerritsen, W. R., & de Vries, I. J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00191 · Cited by 104
Li, T., Zhao, X., Mo, Z., Huang, W., Yan, H., Ling, Z., & Ye, Y. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366342 · Cited by 82
Deregulation of an imprinted gene network in prostate cancer
Ribarska, T., Goering, W., Droop, J., Bastian, K.-M., Ingenwerth, M., & Schulz, W. A. (2014) · Epigenetics · doi:10.4161/epi.28006 · Cited by 73
Bcl-2: A Prime Regulator of Mitochondrial Redox Metabolism in Cancer Cells
Low, I. C. C., Kang, J., & Pervaiz, S. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3851 · Cited by 67
Bioactive lipids and the control of Bax pro-apoptotic activity
Mignard, V., Lalier-Bretaudeau, L., Paris, F., & Vallette, F. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.226 · Cited by 56
LXR Agonist Regulates the Carcinogenesis of PCa via the SOCS3 Pathway
Fu, W., Yao, J., Huang, Y. H., Li, Q., Li, W., Chen, Z., He, F., Zhou, Z., & Yan, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356662 · Cited by 54
A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer
Chang, E. T., Boffetta, P., Adami, H., Cole, P. T., & Mandel, J. S. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9931-2 · Cited by 51
Wang, Y., Gao, S., Liu, G., Jia, R., Fan, D., & Feng, X. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358692 · Cited by 45
Greife, A., Knievel, J., Ribarska, T., Niegisch, G., & Schulz, W. A. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-29 · Cited by 42
The role of cyclin D1 in response to long-term exposure to ionizing radiation
Shimura, T., Fukumoto, M., & Kunugita, N. (2013) · Cell Cycle · doi:10.4161/cc.25746 · Cited by 38
Gene polymorphisms and prostate cancer: the evidence
Dianat, S. S., Margreiter, M., Eckersberger, E., Finkelstein, J. B., Kuehhas, F. E., Herwig, R., Ayati, M., Lepor, H., & Djavan, B. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08973.x · Cited by 36
All-Trans Retinoic Acid Induces DU145 Cell Cycle Arrest through Cdk5 Activation
Lin, E., Chen, M., Huang, C., Hsu, S., Huang, W. J., Lin, M., Wu, J. C.-H., & Lin, H. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358724 · Cited by 32
Cited by
Yan, H., Rao, J., Yuan, J., Gao, L., Huang, W., Zhao, L., & Ren, J. (2017) · Cell Death & Disease · doi:10.1038/s41419-017-0047-y · Cited by 190
Metadata
- Authors
- Luo, G., Wang, M., Wu, X., Tao, D., Xiao, X., Wang, L., Min, F., Zeng, F., & Jiang, G.
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 37
- Issue
- 6
- Pages
- 2209-2220
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2174896178
- Cited by
- 179
- References
- 41
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.